Jean-Francois Toussaint

Title: The Innovations of Jean-Francois Toussaint

Introduction

Jean-Francois Toussaint is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 2 patents, Toussaint's work focuses on innovative solutions for combating infectious diseases.

Latest Patents

Among his latest patents is a groundbreaking immunogenic combination that includes an immunogenic component containing a peptide or polypeptide antigen of a respiratory pathogen. This patent also features an immunogenic component containing a nucleic acid encoding an antigen of the same respiratory pathogen. The formulation is designed for concurrent administration, aiming to elicit a robust immune response specific to the respiratory pathogen. Another significant patent is for an inactivated dengue virus vaccine with an aluminium-free adjuvant. This immunogenic composition is intended for the prevention and/or treatment of diseases caused by the dengue virus.

Career Highlights

Jean-Francois Toussaint is currently associated with GlaxoSmithKline Biologicals SA, where he continues to advance his research in vaccine development. His work has been instrumental in creating effective immunological responses to various pathogens.

Collaborations

Toussaint has collaborated with esteemed colleagues, including Ann-Muriel Steff and Alessandra Vitelli, to further enhance the impact of his research and innovations.

Conclusion

Jean-Francois Toussaint's contributions to immunology and vaccine development highlight his role as a leading inventor in the field. His innovative patents reflect a commitment to improving public health through advanced medical solutions.